Point72 Hong Kong LTD Puma Biotechnology, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $35,238 - $49,907	-5,315 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $47,728 - $61,654	5,315 New	5,315 $49,000
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $14,035 - $20,611	-1,604 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $19,729 - $57,359	1,604 New	1,604 $20,000
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $1,524 - $2,214	-37 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $579 - $819	-12 Reduced 24.49%	37 $2,000
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $537 - $893	9 Added 22.5%	49 $3,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $3,754 - $5,298	40	40 $4,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.